CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Operating expenses:
Selling, general and administrative	$ 3,258	$ 3,321	$ 6,383	$ 7,970
Research and development	1,064	4,439	1,889	10,172
Change in fair value of contingent consideration	16	(161,233)	(3,472)	(97,464)
Total operating costs and expenses	4,338	(153,473)	4,800	(79,322)
(Loss) income from operations	(4,338)	153,473	(4,800)	79,322
Other (loss) income:
Change in fair value of convertible notes	(1,854)	1,795	(3,485)	1,708
Change in fair value of warrants	(542)	5,905	86,187	(14,999)
Loss on issuance of warrants			(75,644)
Loss on embedded forward purchase agreements and derivative liabilities, net		2,905		(20,012)
Other income, net	92	34	195	75
Total other (loss) income, net	(2,304)	10,639	7,253	(33,228)
(Loss) income before taxes	(6,642)	164,112	2,453	46,094
Net (loss) income	$ (6,642)	$ 164,112	$ 2,453	$ 46,094
Basic net (loss) income per share (in dollars per share)	$ (0.6)	$ 304	$ 0.32	$ 87.15
Diluted net (loss) income per share (in dollars per share)	$ (0.6)	$ 304	$ 0.31	$ 87.15
Weighted average shares of common stock outstanding used to compute basic net (loss) income per share	11,090,809	539,840	7,557,472	528,878
Weighted average shares of common stock outstanding used to compute diluted net (loss) income per share	11,090,809	539,840	7,848,566	528,878